Galectin announced the appointment of Khurram Jamil, M.D. as Vice President, Clinical Development. Prior to joining Galectin, Dr. Jamil was the Vice President Hepatology in the critical care division of Mallinckrodt Pharmaceuticals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GALT: